Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR

被引:19
|
作者
Miller, E
Waight, P
Laurichesse, H
Andrews, N
Thornton, C
Sesardic, D
Corbel, M
机构
[1] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England
[2] Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England
[3] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England
关键词
diphtheria/tetanus/perlussis vaccines; MMR; pre-school booster;
D O I
10.1016/S0264-410X(01)00123-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Four acellular diphtheria/tetanus/pertussis (aDTP) vaccines were compared with two diphtheria/tetanus (DT) vaccines given as a pre-school booster to 1033 children aged 4 to < 6 years who had completed primary immunisation with DTP vaccine according to the UK 2, 3 and 4 month schedule; 71 children had received aDTP vaccine and the remaining 962 a whole cell DTP vaccine for primary immunisation. The effect of simultanous administration of a second dose of MMR vaccine was evaluated in 374 (37%). Overall, there was little difference in the frequency of post-vaccination symptoms in DT and aDTP vaccinees, although local reactions occurred more quickly in the aDTP group. The concomitant administration of MMR had no effect on local reactions or fever within 10 days, or on the proportions requiring a doctor's visit in the 4-6 week post-vaccination period. Local reactions 2 3 cm were higher on day 2 in children who had received aDTP for primary immunisation (erythema 32.4% vs. 17.4% for wDTP, P = 0.0012; swelling 28.2% vs. 15.5%, P = 0.0027). Pertussis antibody responses were consistent with the antigen content of the aDTP vaccines. All were more immunogenic with respect to PT - the only pertussis antigen which by itself has been shown to be protective in clinical trials - than a wDTP pre-school booster given in an earlier trial. MMR vaccine had no significant effect on antibody responses to either the pertussis or diphtheria and tetanus antigens. Diphtheria antibody responses in children who had received wDTP for-primary immunisation were 2.8 times higher than in those who had received aDTP vaccine (P < 0.0001); they were also higher in children who had received a single dose of a Haemophilus influenzae type b vaccine containing CRM197 conjugate after 12 months of age. For countries currently using DT vaccines as a pre-school booster, replacement with an aDTP vaccine is unlikely to have a perceptable effect on reactogenicity, at least in children given wDTP for primary immunisation, and would boost antibody levels to antigens known to be associated with protection. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3904 / 3911
页数:8
相关论文
共 50 条
  • [41] A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults
    Thierry-Carstensen, Birgit
    Jordan, Karina
    Uhlving, Hilde Hylland
    Dalby, Tine
    Sorensen, Charlotte
    Jensen, Anders Morup
    Heilmann, Carsten
    [J]. VACCINE, 2012, 30 (37) : 5464 - 5471
  • [42] IMMUNOGENICITY AND REACTOGENICITY OF TAKEDA ACELLULAR PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS VACCINE IN 2-MONTH-OLD AND 3-MONTH-OLD CHILDREN IN JAPAN
    KAMIYA, H
    NII, R
    MATSUDA, T
    YASUDA, N
    CHRISTENSON, PD
    CHERRY, JD
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1992, 146 (10): : 1141 - 1147
  • [43] Safety and immunogenicity of combined diphtheria tetanus pertussis (whole cell and acellular) Haemophilus influenzae b conjugate vaccines administered to Indonesian children
    Richie, E
    Punjabi, NH
    Harjanto, SJ
    Wangsasaputral, F
    Sukandar, M
    Supriatman, M
    Simanjuntak, CH
    Que, JU
    Cryz, SJ
    [J]. VACCINE, 1999, 17 (11-12) : 1384 - 1393
  • [44] Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate hepatitis-B Vaccines and combined diphtheria-tetanus-acellular pertussis vaccines
    Shinefield, H
    Black, S
    Thear, M
    Coury, D
    Reisinger, K
    Rothstein, E
    Xu, J
    Hartzel, J
    Evans, B
    Digilio, L
    Schödel, F
    Brown, MLH
    Kuter, B
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (04) : 287 - 292
  • [45] Randomised study of the possible adjuvant effect of BCG vaccine on the immunogenicity of diphtheria tetanus acellular pertussis vaccine in Senegalese infants
    Simondon, F
    Preziosi, MP
    Pinchinat, S
    Yam, A
    Chabirand, L
    Wassilak, S
    Pines, E
    Trape, JF
    Salomon, H
    Hoffenbach, A
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (01) : 23 - 29
  • [46] ACELLULAR PERTUSSIS-VACCINE - IMMUNOGENICITY AND SAFETY OF AN ACELLULAR PERTUSSIS VS A WHOLE CELL PERTUSSIS-VACCINE COMBINED WITH DIPHTHERIA AND TETANUS TOXOIDS AS A BOOSTER IN 18-MONTH TO 24-MONTH OLD CHILDREN
    PICHICHERO, ME
    BADGETT, JT
    RODGERS, GC
    MCLINN, S
    TREVINOSCATTERDAY, B
    NELSON, JD
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (04) : 352 - 363
  • [47] Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine
    Kosuwon, P
    Warachit, B
    Hutagalung, Y
    Borkird, T
    Kosalaraksa, P
    Bock, HL
    Poovorawan, Y
    [J]. VACCINE, 2003, 21 (27-30) : 4194 - 4200
  • [48] NEWBORN UNIVERSAL IMMUNIZATION AGAINST HEPATITIS-B - IMMUNOGENICITY AND REACTOGENICITY OF SIMULTANEOUS ADMINISTRATION OF DIPHTHERIA/TETANUS/PERTUSSIS (DTP) AND ORAL POLIO VACCINES WITH HEPATITIS-B VACCINE AT 0, 2 AND 6 MONTHS OF AGE
    ARISTEGUI, J
    MUNIZ, J
    LEGORBURU, AP
    IMAZ, M
    ARRATE, JP
    SUAREZ, MD
    GOIRI, MD
    [J]. VACCINE, 1995, 13 (11) : 973 - 977
  • [49] Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine:: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster
    Mallet, E
    Matisse, N
    Mathieu, N
    Langue, J
    Boisnard, F
    Soubeyrand, B
    [J]. VACCINE, 2004, 22 (11-12) : 1415 - 1422
  • [50] Haemophilus influenzae type B (Hib) antibody responses in children given diphtheria-tetanus-acellular pertussis-Hib combination vaccines
    Finn, A
    Blondeau, C
    Bell, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06): : 2117 - 2118